TruePfizer at this point has become a liability for Resapp, we...

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #

First 350 Last

Share
Profile

Follow
ozgoldtrader

6,223 Posts.

207

22/06/22

22:55

Post #: 62148246
Share

Originally posted by pilko3: ↑

that the screening tool required further testing/and yes sir Aras you have nailed the thing and have highlighted the real reason we look like we have been setup like fools with the whole way this Pfizer thing has been going down...listen up.
The large part of the capital from Pfizer was allocated for further study/testing/approval then commercialisation of this Covid screening tool.
The testing failed but wait...if RAP and Pfizer were aware that the Covid test required further testing and then had to be sent for approval they must have already been aware of the fact it was at that stage "less than perfect" to say the least. RAP had already stated the figures they had produced from their trials. But, they knew that the figures ere a tad wobbly as the Covid test required more work so the current figures were not the final figures achievable.
So did RAP and Pfizer then decide to use the retesting of the Covid screening tool knowing all the while the chances of the results being the same or better were indeed slim therefore the optional bid would end up being the lower of the two options chosen at 14.6 cents? IT would seem we have fallen victim to the old three card trick...pretending that an unknown (with the large chance of different results after testing) would swing Pfizer to the lower bid and be the justification for that swing.
They were going to work on knocking the screening tool for Covid test into shape by admission as this is what they declared that much of the Pfizer funding was going to be used for...retesting the Covid Screening tool.
TK comes out and says in his opinion the results should be OK for the Pfizer retest so we all breath some sort of collective sigh of relief. Since when does a test that requires further work, testing etc to ready it for approval all of a sudden become the only criteria for Pfizer (with TK's blessing note) to go off re keeping the bid of 20.7 cents or dropping it to 14.6 cents.
If this extremely pertinent fact can be proven nd shown to be true then it is IMHO a damning indictment as to how this whole buyout debacle has been handled and presented...the implications and dodgy treatment of the way the bid and conditions have been progressed would make any good legal eagle blush. The BOD could have painted themselves into a corner with not many avenues of excuse around this one point.
Thanks ARAS this point is just about as important as it gets on many levels. The test required further work and testing...however we can use it to facilitate getting the bid down to te lowest value as presented by the independent valuer...that's good, very good...we do like that. They will never see through this one. IMHO DYOR and stand by,,,

Expand

True

Pfizer at this point has become a liability for Resapp,

we are in fact better off without it

Go away Pfizer!

Leave Resapp alone. You are not welcome anymore.

RAP Price at posting: 12.0¢ Sentiment: Buy Disclosure: Not Held
2 Upvote

0 Great analysis

Reply

Top Stories

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

BUX

Buxton projects new graphite province discovery at WA Narryer play

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

There are more pages in this discussion • 76 more messages in this thread...

First 350 Last

Add RAP (ASX) to my watchlist

TruePfizer at this point has become a liability for Resapp, we...

Top Stories

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Buxton projects new graphite province discovery at WA Narryer play

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

BCI reaches close of funding facility for salt-first part of Mardie project

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Featured News